CURE Pharmaceutical’s Subsidiary Sera Labs Launches National...

"CURE Pharmaceutical’s Subsidiary Sera Labs Launches National Television, Radio & Digital Advertising Campaign for Nutri-Strips Sleep A.S.A.P Sleep A.S.A.P provides proof of concept and monetization for CURE’s patented oral thin-film technology."


"Sleep A.S.A.P™’s proprietary formulation for sleep was developed by CURE’s industryleading scientists who blended five of the most powerful sleep ingredients including Melatonin, Gamma-aminobutyric Acid (GABA), L-Theanine, Vitamin B6, and BetaCaryophyllene (BCP) into one dose to help you get to sleep and stay asleep."


“Nutri-Strips serve as a strong proof of concept for CURE’s patented oral thin-film technology and this campaign highlights the fact that we can successfully commercialize and monetize this technology through our subsidiary Sera Labs,” said Rob Davidson, CEO of CURE. “We foresee this type of advertising exposure as an opportunity to further introduce the world to the thin-film technology, which is a staple of both CURE's pharmaceutical and wellness verticals, while generating consumer sales..."


030321 Cure Pharmaceuticals news release
.
Download • 114KB


Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887

Website: www.medicalandpharmainsider.com

Email mail@medicalandpharmainsider.com

MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2021 Medical and Pharma Insider and FC Global Strategies LLC